E. Yoko Furuya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
E. Yoko Furuya has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Elaine L. Larson
Columbia University School of Nursing, New York, NY
2 shared publications Elaine Larson
School of Nursing, Mailman School of Public Health, Columbia University, New York, New York
2 shared publicationsFranklin D. Lowy
2 shared publications- Gilad Kuperman
Department of Biomedical Informatics, Columbia University, New York, NY
2 shared publications Haomiao Jia
Columbia University
2 shared publications- Tiffani J. Bright
Duke University Medical Center, Division of Clinical Informatics, 2200 West Main St., Suite 600, Durham, NC 27710, USA
2 shared publications
Latest Publications
- 1 December 2014
- Published by Elsevier in American Journal of Infection Control
- Vol. 42 (12) , 1296-1302
Burden of present-on-admission infections and health care-associated infections, by race and ethnicity
- 1 December 2014
- Published by Elsevier in American Journal of Infection Control
- Vol. 42 (12) , 1296-1302
Burden of present-on-admission infections and health care-associated infections, by race and ethnicity
- 1 August 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (8) , 825-831
Impact of the 2009 Influenza A (H1N1) Pandemic on Healthcare Workers at a Tertiary Care Center in New York City
Background and Objective.: Assessing the impact of 2009 influenza A (H1N1) on healthcare workers (HCWs) is important for pandemic planning.Methods.: We retrospectively analyzed employee health records of HCWs at a tertiary care center in New York City with influenza-like illnesses (ILI) and confirmed influenza from March 31, 2009, to February 28, 2010. We evaluated HCWs' clinical presentations during the first and second wave of the pandemic, staff absenteeism, exposures among HCWs, and association between high-risk occupational exposures to respiratory secretions and infection.Results.: During the pandemic, 40% (141/352) of HCWs with ILI tested positive for influenza, representing a 1% attack rate among our 13,066 employees. HCWs with influenza were more likely to have fever, cough, and tachycardia. When compared with the second wave, cases in the first wave were sicker and at higher risk of exposure to patients' respiratory secretions (P = .049). HCWs with ILI- with and without confirmed influenza-missed on average 4.7 and 2.7 work days, respectively (P = .001). Among HCWs asked about working while ill, 65% (153/235) reported they did so (mean, 2 days).Conclusions.: HCWs in the first wave had more severe ILI than those in the second wave and were more likely to be exposed to patients' respiratory secretions. HCWs with ILI often worked while ill. Timely strategies to educate and support HCWs were critical to managing this population during the pandemic.
- 1 August 2013
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 34 (8) , 825-831
Impact of the 2009 Influenza A (H1N1) Pandemic on Healthcare Workers at a Tertiary Care Center in New York City
Background and Objective.: Assessing the impact of 2009 influenza A (H1N1) on healthcare workers (HCWs) is important for pandemic planning.Methods.: We retrospectively analyzed employee health records of HCWs at a tertiary care center in New York City with influenza-like illnesses (ILI) and confirmed influenza from March 31, 2009, to February 28, 2010. We evaluated HCWs' clinical presentations during the first and second wave of the pandemic, staff absenteeism, exposures among HCWs, and association between high-risk occupational exposures to respiratory secretions and infection.Results.: During the pandemic, 40% (141/352) of HCWs with ILI tested positive for influenza, representing a 1% attack rate among our 13,066 employees. HCWs with influenza were more likely to have fever, cough, and tachycardia. When compared with the second wave, cases in the first wave were sicker and at higher risk of exposure to patients' respiratory secretions (P = .049). HCWs with ILI- with and without confirmed influenza-missed on average 4.7 and 2.7 work days, respectively (P = .001). Among HCWs asked about working while ill, 65% (153/235) reported they did so (mean, 2 days).Conclusions.: HCWs in the first wave had more severe ILI than those in the second wave and were more likely to be exposed to patients' respiratory secretions. HCWs with ILI often worked while ill. Timely strategies to educate and support HCWs were critical to managing this population during the pandemic.
- Open Access
- 26 November 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 432
Long-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia
Background: Hospital associated infections are major problems, which are increasing in incidence and very costly. However, most research has focused only on measuring consequences associated with the initial hospitalization. We explored the long-term consequences of infections in elderly Medicare patients admitted to an intensive care unit (ICU) and discharged alive, focusing on: sepsis, pneumonia, central-line-associated bloodstream infections (CLABSI), and ventilator-associated pneumonia (VAP); the relationships between the infections and long-term survival and resource utilization; and how resource utilization was related to impending death during the follow up period. Methods: Clinical data and one year pre- and five years post-index hospitalization Medicare records were examined. Hazard ratios (HR) and healthcare utilization incidence ratios (IR) were estimated from state of the art econometric models. Patient demographics (i.e., age, gender, race and health status) and Medicaid status (i.e., dual eligibility) were controlled for in these models. Results: In 17,537 patients, there were 1,062 sepsis, 1,802 pneumonia, 42 CLABSI and 52 VAP cases. These subjects accounted for 62,554 person-years post discharge. The sepsis and CLABSI cohorts were similar as were the pneumonia and VAP cohorts. Infection was associated with increased mortality (sepsis HR = 1.39, P < 0.01; and pneumonia HR = 1.58, P < 0.01) and the risk persisted throughout the follow-up period. Persons with sepsis and pneumonia experienced higher utilization than controls (e.g., IR for long-term care utilization for those with sepsis ranged from 2.67 to 1.93 in years 1 through 5); and, utilization was partially related to impending death. Conclusions: The infections had significant and lasting adverse consequences among the elderly. Yet, many of these infections may be preventable. Investments in infection prevention interventions are needed in both community and hospitals settings.
- 26 November 2012
- Published by Springer Nature in BMC Health Services Research
- Vol. 12 (1) , 432
Open AccessLong-term survival and healthcare utilization outcomes attributable to sepsis and pneumonia
Background: Hospital associated infections are major problems, which are increasing in incidence and very costly. However, most research has focused only on measuring consequences associated with the initial hospitalization. We explored the long-term consequences of infections in elderly Medicare patients admitted to an intensive care unit (ICU) and discharged alive, focusing on: sepsis, pneumonia, central-line-associated bloodstream infections (CLABSI), and ventilator-associated pneumonia (VAP); the relationships between the infections and long-term survival and resource utilization; and how resource utilization was related to impending death during the follow up period. Methods: Clinical data and one year pre- and five years post-index hospitalization Medicare records were examined. Hazard ratios (HR) and healthcare utilization incidence ratios (IR) were estimated from state of the art econometric models. Patient demographics (i.e., age, gender, race and health status) and Medicaid status (i.e., dual eligibility) were controlled for in these models. Results: In 17,537 patients, there were 1,062 sepsis, 1,802 pneumonia, 42 CLABSI and 52 VAP cases. These subjects accounted for 62,554 person-years post discharge. The sepsis and CLABSI cohorts were similar as were the pneumonia and VAP cohorts. Infection was associated with increased mortality (sepsis HR = 1.39, P < 0.01; and pneumonia HR = 1.58, P < 0.01) and the risk persisted throughout the follow-up period. Persons with sepsis and pneumonia experienced higher utilization than controls (e.g., IR for long-term care utilization for those with sepsis ranged from 2.67 to 1.93 in years 1 through 5); and, utilization was partially related to impending death. Conclusions: The infections had significant and lasting adverse consequences among the elderly. Yet, many of these infections may be preventable. Investments in infection prevention interventions are needed in both community and hospitals settings.
- 1 February 2012
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 45 (1) , 120-128
Development and evaluation of an ontology for guiding appropriate antibiotic prescribing
- 1 February 2012
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 45 (1) , 120-128
Development and evaluation of an ontology for guiding appropriate antibiotic prescribing
- 1 April 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (4) , 323-332
Challenges of Applying the SHEA/HICPAC Metrics for Multidrug-Resistant Organisms to a Real-World Setting
Objective.: To test in a real-world setting the recommendations for measuring infection with multidrug-resistant organisms (MDRO) from the Society for Healthcare Epidemiology of America (SHEA) and the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC).Methods.: Using data from 3 hospital settings within a healthcare network, we applied the SHEA/HICPAC recommendations to measure methicillin-resistant Staphylococcus aureus (MRSA) infection and colonization. Data were obtained from the hospitals' electronic surveillance system and were supplemented by manual medical record review as necessary. Additionally, we tested (1) different definitions for nosocomial incidence, (2) the effect of excluding patients not at risk from the denominator for hospital-onset incidence, and (3) the appropriate time period to use when including or excluding patients with a prior history of MRSA infection or colonization from nosocomial rates. Negative binomial regression models were used to test for differences between rate definitions. A rating scale was created for each metric, assessing the extent to which manual or electronic data elements were required.Results.: There was no statistically significant difference between using 72 hours or 3 calendar days as the cutoff to define hospital-onset incidence. Excluding patients not at risk from the denominator when calculating hospital-onset incidence led to statistically significant increases in rates. When excluding patients with a prior history of MRSA infection or colonization from nosocomial incidence rates, rates were similar regardless of whether we looked at 1, 2, or 3 years' worth of prior data.Conclusions.: The SHEA/HICPAC MDRO metrics are useful but can be challenging to implement. We include in our description of the data sources and processes required to calculate these metrics information that may simplify the process for institutions.
- 1 April 2011
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 32 (4) , 323-332
Challenges of Applying the SHEA/HICPAC Metrics for Multidrug-Resistant Organisms to a Real-World Setting
Objective.: To test in a real-world setting the recommendations for measuring infection with multidrug-resistant organisms (MDRO) from the Society for Healthcare Epidemiology of America (SHEA) and the Centers for Disease Control and Prevention's Healthcare Infection Control Practices Advisory Committee (HICPAC).Methods.: Using data from 3 hospital settings within a healthcare network, we applied the SHEA/HICPAC recommendations to measure methicillin-resistant Staphylococcus aureus (MRSA) infection and colonization. Data were obtained from the hospitals' electronic surveillance system and were supplemented by manual medical record review as necessary. Additionally, we tested (1) different definitions for nosocomial incidence, (2) the effect of excluding patients not at risk from the denominator for hospital-onset incidence, and (3) the appropriate time period to use when including or excluding patients with a prior history of MRSA infection or colonization from nosocomial rates. Negative binomial regression models were used to test for differences between rate definitions. A rating scale was created for each metric, assessing the extent to which manual or electronic data elements were required.Results.: There was no statistically significant difference between using 72 hours or 3 calendar days as the cutoff to define hospital-onset incidence. Excluding patients not at risk from the denominator when calculating hospital-onset incidence led to statistically significant increases in rates. When excluding patients with a prior history of MRSA infection or colonization from nosocomial incidence rates, rates were similar regardless of whether we looked at 1, 2, or 3 years' worth of prior data.Conclusions.: The SHEA/HICPAC MDRO metrics are useful but can be challenging to implement. We include in our description of the data sources and processes required to calculate these metrics information that may simplify the process for institutions.
- 6 November 2008
- p. 888
Creating an ontology for an antibiotic prescribing decision support system.
One of the most effective and immediate solutions to the growing antimicrobial resistance problem is to address the role of inappropriate prescribing. Ontologies can support judicious prescribing, but use of an ontology as part of a CDSS to support antibiotic therapeutic planning has not been fully explored. The proposed research project will create and evaluate an ontology for supporting a CDSS module that generates an antibiotic-mismatch alert to guide appropriate antibiotic prescribing.
- 6 November 2008
- p. 888
Creating an ontology for an antibiotic prescribing decision support system.
One of the most effective and immediate solutions to the growing antimicrobial resistance problem is to address the role of inappropriate prescribing. Ontologies can support judicious prescribing, but use of an ontology as part of a CDSS to support antibiotic therapeutic planning has not been fully explored. The proposed research project will create and evaluate an ontology for supporting a CDSS module that generates an antibiotic-mismatch alert to guide appropriate antibiotic prescribing.
- 1 August 2007
- Published by Elsevier in American Journal of Infection Control
- Vol. 35 (6) , 359-366
Community-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainment
- 1 August 2007
- Published by Elsevier in American Journal of Infection Control
- Vol. 35 (6) , 359-366
Community-associated methicillin-resistant Staphylococcus aureus prevalence: How common is it? A methodological comparison of prevalence ascertainment
- 1 January 2006
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 4 (1) , 36-45
Antimicrobial-resistant bacteria in the community setting
Over the past decade, antimicrobial resistance has emerged as a major public-health crisis. Common bacterial pathogens in the community such as Streptococcus pneumoniae have become progressively more resistant to traditional antibiotics. Salmonella strains are beginning to show resistance to crucial fluoroquinolone drugs. Community outbreaks caused by a resistant form of Staphylococcus aureus, known as community-associated meticillin (formerly methicillin)-resistant Staphylococcus aureus, have caused serious morbidity and even deaths in previously healthy children and adults. To decrease the spread of such antimicrobial-resistant pathogens in the community, a greater understanding of their means of emergence and survival is needed.
- 1 January 2006
- Published by Springer Nature in Nature Reviews Microbiology
- Vol. 4 (1) , 36-45
Antimicrobial-resistant bacteria in the community setting
Over the past decade, antimicrobial resistance has emerged as a major public-health crisis. Common bacterial pathogens in the community such as Streptococcus pneumoniae have become progressively more resistant to traditional antibiotics. Salmonella strains are beginning to show resistance to crucial fluoroquinolone drugs. Community outbreaks caused by a resistant form of Staphylococcus aureus, known as community-associated meticillin (formerly methicillin)-resistant Staphylococcus aureus, have caused serious morbidity and even deaths in previously healthy children and adults. To decrease the spread of such antimicrobial-resistant pathogens in the community, a greater understanding of their means of emergence and survival is needed.
- 1 October 2003
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 3 (5) , 464-469
Antimicrobial strategies for the prevention and treatment of cardiovascular infections
- 1 October 2003
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 3 (5) , 464-469
Antimicrobial strategies for the prevention and treatment of cardiovascular infections